Alcresta Therapeutics Announces FDA Clearance for the Next-Generation RELiZORB® Digestive Enzyme Cartridge

/PRNewswire/ -- Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel enzyme-based products, today...

Related Keywords

Boston ,Massachusetts ,United States ,Waltham ,Dan Orlando ,Mark Puder ,Natalie Bronfin ,Dave Recker ,Radiological Health ,Therapeutics Inc ,Drug Administration ,Alcresta Therapeutics Inc ,Prnewswire Alcresta Therapeutics Inc ,Chief Executive Officer ,Boston Children ,Acting Chief Medical Officer ,Athyrium Capital Management ,Bessemer Venture Partners ,Healthquest Capital ,Frazier Healthcare ,Media Contact ,